As of January 27, the global tally of SARS-CoV-2 infections has surpassed 100 million, with fatalities reaching 2 million. Remarkably, approximately 30 million confirmed cases remain untreated with ...
As the summer of 2021 started to unfold, many Americans thought the pandemic was beginning to fizzle out. But that illusion is over and the country is once more besieged by the coronavirus. Intensive ...
Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. TxGNN is the first AI model specifically developed to identify ...
We're all familiar with the dilemma: It takes an average of 9.5 to 15 years to develop a new drug at a cost as high as $2.6 billion, with only a fraction of the drugs making it to market. With AI and ...
London, July 1, 2024: The Drug Repurposing & Repositioning Inventions Boardroom provided a deep dive on this important topic with industry experts from NLO, 3D-PharmXchange, and the Repo4EU consortium ...
In a study published in the journal Nature Communications, researchers screened ReFRAME (short for repurposing, focused rescue, and accelerated Medchem), a drug-repurposing library, for drugs against ...
Cancer continues to be a pressing global health challenge, with pancreatic ductal adenocarcinoma (PDAC), colorectal cancer (CRC), and breast cancer (BC) ranking among the most prevalent and deadly. As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback